Original articleTreatment-related deaths in small cell lung cancer trials: can patients at risk be identified?
References (24)
- et al.
Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis
Eur J Cancer
(1993) - et al.
The impact of clinical trials on the treatment of lung cancer
Clin Oncol
(1993) - et al.
Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of the bronchus: ten year follow-up
Lancet
(1973) - et al.
Intrauterine devices and pelvic inflammatory disease: an international perspective
Lancet
(1992) - et al.
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
Eur J Cancer
(1993) Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer
Respir Med
(1989)- et al.
Luncer cancer
- et al.
Longevity in small cell lung cancer — a report to the lung cancer subcommittee of the United Kingdom Coordinating Committee for Cancer Research
Br J Cancer
(1990) - et al.
Alternating radiotherapy and chemotherapy with doxorubicin, etoposide, cyclophosphamide, and cisplatin in limited small cell lung cancer
Cancer Treat Symp
(1985) - et al.
Can long term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status?
Br J Cancer
(1994)
Patients at risk of chemotherapy-associated toxicity in small cell lung cancer
Br J Cancer
(1989)
Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer
Br J Cancer
(1989)
Cited by (0)
- 1
Members: N. Thatcher (Chairman), N.M. Bleehen, J.J. Bolger, P.I. Clark, D.J. Girling, P.S. Hasleton, P. Hopwood, F.R. Macbeth, D. Machin, K. Moghissi, M.I. Saunders, R.J. Stephens, R.J. White.
Copyright © 1994 Published by Elsevier Ireland Ltd.